Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
povidone-iodine + triamcinolone acetonide + lidocaine hydrochloride + bupivacaine
- Development stage
- Unknown
- Lead developer
- Asclemed USA
- Modality
- Small Molecules
- Administration
- Topical, Parenteral
01
Overview
**povidone-iodine + triamcinolone acetonide + lidocaine hydrochloride + bupivacaine** is a four-component combination small-molecule drug kit associated with Asclemed USA for local or regional analgesia and anesthesia. The product combines **lidocaine hydrochloride** and **bupivacaine** as amide local anesthetics that reduce nerve conduction by blocking voltage-gated sodium channels, **triamcinolone acetonide** as a synthetic glucocorticoid receptor agonist used for anti-inflammatory effects, and **povidone-iodine** as a topical antiseptic for procedural skin preparation. Based on the provided context, the kit has been described under the brand name **MLK F4 KIT** and appears to be marketed or referenced as an **unapproved drug** whose labeling has not been approved by the FDA.
- Brand names
- MLK F4 KIT
- Other names
- povidone-iodine + triamcinolone acetonide + lidocaine hydrochloride + bupivacaine
02
Targets
NaV (Voltage-gated sodium channels)GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on povidone-iodine + triamcinolone acetonide + lidocaine hydrochloride + bupivacaine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on povidone-iodine + triamcinolone acetonide + lidocaine hydrochloride + bupivacaine.